{"id":1894,"date":"2021-01-08T00:00:00","date_gmt":"2021-01-07T23:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=1894"},"modified":"2022-09-05T15:20:19","modified_gmt":"2022-09-05T13:20:19","slug":"idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/","title":{"rendered":"IDL Biotech licensierar sin manuella ELISA tum\u00f6rmark\u00f6rproduktlinje till Beckman Coulter Diagnostics"},"content":{"rendered":"<p>IDL Biotech vill fokusera p\u00e5 snabba diagnostiska tester och automatiserade analyser av sina tum\u00f6rmark\u00f6rer. Genom att licensiera plattformen ELISA till Beckman Coulter kan vi fokusera v\u00e5ra resurser p\u00e5 att effektivisera och utveckla de andra plattformarna, s\u00e4ger Gunnar Wahlberg, VD f\u00f6r IDL Biotech.<\/p>\n\n\n\n<p>IDL Biotech meddelade att man har tecknat ett avtal med Beckman Coulter om licensiering av IDLs hela sortiment av manuella ELISA tum\u00f6rmark\u00f6rer. Licensavtalet ger Beckman Coulter globala f\u00f6rs\u00e4ljningsr\u00e4ttigheter och g\u00f6r det m\u00f6jligt f\u00f6r IDL att s\u00e4lja material f\u00f6r produktion och erh\u00e5lla royalties. Avtalet har formellt kontrasignerats av Immunotech, ett dotterbolag till Beckman Coulter.<\/p>\n\n\n\n<p>De tum\u00f6rmark\u00f6rer som ing\u00e5r i ELISA-plattformen \u00e4r TPS\u00ae, TPAcyk, MonoTotal\u00ae och UBC\u00ae.<\/p>\n\n\n\n<p>L\u00e4s hela pressmeddelandet&nbsp;<strong><a href=\"https:\/\/news.cision.com\/se\/idl-biotech\/r\/idl-biotech-licensierar-sin-produktlinje-for-tumormarkorer-pa-den-manuella-elisa-plattformen-till-be,c3265224\">h\u00e4r<\/a>&nbsp;<\/strong>Svenska<\/p>","protected":false},"excerpt":{"rendered":"<p>IDL Biotech wants to focus on rapid diagnostic tests and automated assays of its tumor markers. By licensing the platform ELISA to Beckman Coulter, we can focus our resources on streamlining and developing the other platforms,\u0094 said Gunnar Wahlberg, CEO of IDL Biotech. IDL Biotech announced it has signed an agreement with Beckman Coulter for [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":2550,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11],"tags":[],"dipi_cpt_category":[],"class_list":["post-1894","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"IDL Biotech wants to focus on rapid diagnostic tests and automated assays of its tumor markers. By licensing the platform ELISA to Beckman Coulter, we can focus our resources on streamlining and developing the other platforms,\u0094 said Gunnar Wahlberg, CEO of IDL Biotech. IDL Biotech announced it has signed an agreement with Beckman Coulter for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-05T13:20:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1002\" \/>\n\t<meta property=\"og:image:height\" content=\"657\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/\"},\"author\":{\"name\":\"marie\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\"},\"headline\":\"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics\",\"datePublished\":\"2021-01-07T23:00:00+00:00\",\"dateModified\":\"2022-09-05T13:20:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/\"},\"wordCount\":136,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2833web.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/\",\"name\":\"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2833web.jpg\",\"datePublished\":\"2021-01-07T23:00:00+00:00\",\"dateModified\":\"2022-09-05T13:20:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2833web.jpg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2833web.jpg\",\"width\":1002,\"height\":657},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/08\\\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\",\"name\":\"marie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"caption\":\"marie\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/marie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/","og_locale":"sv_SE","og_type":"article","og_title":"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics","og_description":"IDL Biotech wants to focus on rapid diagnostic tests and automated assays of its tumor markers. By licensing the platform ELISA to Beckman Coulter, we can focus our resources on streamlining and developing the other platforms,\u0094 said Gunnar Wahlberg, CEO of IDL Biotech. IDL Biotech announced it has signed an agreement with Beckman Coulter for [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/se\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2021-01-07T23:00:00+00:00","article_modified_time":"2022-09-05T13:20:19+00:00","og_image":[{"width":1002,"height":657,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg","type":"image\/jpeg"}],"author":"marie","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"marie","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/"},"author":{"name":"marie","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000"},"headline":"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics","datePublished":"2021-01-07T23:00:00+00:00","dateModified":"2022-09-05T13:20:19+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/"},"wordCount":136,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg","articleSection":["News"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/","url":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/","name":"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg","datePublished":"2021-01-07T23:00:00+00:00","dateModified":"2022-09-05T13:20:19+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2833web.jpg","width":1002,"height":657},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2021\/01\/08\/idl-biotech-licenses-its-manual-elisa-tumor-marker-product-line-to-beckman-coulter-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000","name":"marie","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","caption":"marie"},"url":"https:\/\/idldiagnostics.com\/se\/author\/marie\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=1894"}],"version-history":[{"count":4,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1894\/revisions"}],"predecessor-version":[{"id":3718,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1894\/revisions\/3718"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2550"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=1894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=1894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=1894"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=1894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}